Maria Stefania Sinicropi Selected Research

Morning Sickness

1/2022	Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs.
1/2017	Old Drug Scaffold, New Activity: Thalidomide-Correlated Compounds Exert Different Effects on Breast Cancer Cell Growth and Progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Stefania Sinicropi Research Topics

Disease

36	Neoplasms (Cancer) 05/2022 - 01/2012
18	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2012
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2020 - 01/2014
2	COVID-19 10/2022 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2018
2	Morning Sickness 01/2022 - 01/2017
2	Carcinogenesis 10/2021 - 01/2020
2	Huntington Disease (Huntington's Disease) 10/2020 - 10/2018
2	Kidney Diseases (Kidney Disease) 01/2020 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 10/2018 - 08/2010
2	Alzheimer Disease (Alzheimer's Disease) 10/2018 - 07/2014
2	Ovarian Neoplasms (Ovarian Cancer) 12/2017 - 01/2015
2	Heart Diseases (Heart Disease) 12/2017 - 12/2017
1	Cutaneous Leishmaniasis 05/2022
1	Multiple Myeloma 01/2022
1	Communicable Diseases (Infectious Diseases) 11/2021
1	Glioblastoma (Glioblastoma Multiforme) 10/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2021
1	Infections 07/2021
1	Histiocytoma 05/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Mesothelioma 01/2020
1	Nose Neoplasms 01/2020
1	Osteoporosis 01/2020
1	Obesity 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2018
1	Coronary Disease (Coronary Heart Disease) 12/2017

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 10/2022 - 10/2014
9	Biological ProductsIBA 12/2020 - 07/2010
7	carbazoleIBA 01/2020 - 07/2014
5	ResveratrolIBA 05/2021 - 09/2013
5	MetalsIBA 01/2020 - 07/2010
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	GoldIBA 05/2020 - 12/2016
4	SilverIBA 05/2020 - 12/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2021
3	carbeneIBA 04/2022 - 12/2016
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2020 - 01/2016
3	ellipticineIBA 12/2018 - 01/2017
3	MercuryIBA 12/2017 - 01/2014
3	titanoceneIBA 11/2015 - 06/2013
2	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2021
2	Thalidomide (Thalomid)FDA Link 01/2022 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 12/2017
2	TubulinIBA 10/2021 - 05/2020
2	Estrogen ReceptorsIBA 05/2021 - 01/2012
2	Cyclopentanes (Cyclopentane)IBA 05/2020 - 11/2015
2	LigandsIBA 05/2020 - 01/2012
2	CarbazolesIBA 01/2020 - 08/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 02/2013
2	QuercetinIBA 01/2019 - 11/2017
2	LipidsIBA 01/2019 - 01/2014
2	PolyphenolsIBA 01/2019 - 12/2013
2	Hormones (Hormone)IBA 03/2017 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2014
2	Estrogens (Estrogen)FDA Link 01/2015 - 01/2012
2	AntioxidantsIBA 01/2014 - 10/2009
1	Bradykinin B2 Receptor AntagonistsIBA 10/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	Antimalarials (Antimalarial Agents)IBA 10/2022
1	Immunologic Factors (Immunomodulators)IBA 10/2022
1	VaccinesIBA 10/2022
1	Angiotensin Receptor AntagonistsIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Imatinib Mesylate (Gleevec)FDA Link 10/2021
1	1-(2-chloroethyl)-1-nitrosourea (CNU)IBA 10/2021
1	PyrrolesIBA 10/2021
1	Anti-Infective Agents (Microbicides)IBA 07/2021
1	triclocarbanIBA 07/2021
1	CosmeticsIBA 07/2021
1	Cell Cycle ProteinsIBA 05/2021
1	LipopolysaccharidesIBA 05/2021
1	Dinoprostone (PGE2)FDA Link 05/2021
1	Vinca AlkaloidsIBA 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	Colchicine FDA LinkGeneric 12/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 10/2020
1	3-(2,2,2-trimethylhydrazine)propionateIBA 10/2020
1	human SLC22A5 proteinIBA 10/2020
1	imidazoleIBA 05/2020
1	Tubulin ModulatorsIBA 05/2020
1	NickelIBA 01/2020
1	CadmiumIBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	XenobioticsIBA 01/2020
1	pyridoclaxIBA 01/2020
1	CopperIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 07/2019
1	Methanol (Carbinol)IBA 07/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	ChromatinIBA 01/2019
1	AlkaloidsIBA 12/2018
1	CaspasesIBA 12/2018
1	IronIBA 10/2018

Therapy/Procedure

11	Therapeutics 10/2022 - 06/2013
1	Drug Therapy (Chemotherapy) 12/2018